UNSPSC 51172327: Sodium lactate

This classification denotes an electrolyte replacement agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TU7HW0W0QT. European Medicines Agency schedules Sodium lactate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15300MIG. Sodium lactate generally arises in the molecular formula C3H6O3.NA. The term SODIUM LACTATE is a United States Homeopathic Pharmacopoeia Name designation. Most nations schedule sodium lactate under HS 29181100 and SITC 51391.

As of Q4 2014, SODIUM LACTATE remains the US FDA Preferred Term for this commodity. Sodium lactate bears US NLM identifiers UMLS ID C0142874 and NCI Concept Code C47726. SMILES: OC(C)C(=O)O.

UNSPSC 51172327 Sodium lactate, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The code's definition targets sodium lactate—a chemical compound used in food preservation, medical solutions, and industrial applications—yet the recent opportunities posted under this code involve offender drug testing services, water treatment chemicals (sodium hypochlorite and sulfuric acid), pharmaceutical procurement, and direct-to-manufacturer prescription programs. Only the Orange County Public Works IFB for sodium hypochlorite and sulfuric acid relates tangentially to industrial chemical supply, but neither sodium lactate nor similar biochemical products appear as line items in the documented solicitations. The mismatch suggests either miscoding by issuing bodies or that sodium lactate is bundled into larger chemical or pharmaceutical RFPs without direct itemization in the posted summaries.

Recent activity spans Texas, California, Minnesota, and Oregon through county-level governments (Collin County, Orange County), state agencies (Texas Health and Human Services Commission, Minnesota Department of Administration), and multistate cooperative purchasing vehicles (MMCAP). The Orange County IFB (solicitation 0803008401RE, due March 27, 2026) is the only opportunity with direct relevance to industrial chemical supply; it sought five-year pricing for sodium hypochlorite and sulfuric acid with five percent preference for certified Orange County Local Small Businesses and eight percent preference for Disabled Veteran Business Enterprises. The remaining opportunities—Collin County's offender drug testing RFP (due July 23, 2026), Texas HHS's TPI Direct-to-Manufacturer Prescriptions RFI (April 3, 2026), and MMCAP's generic pharmaceuticals RFP (due March 26, 2026)—fall outside sodium lactate's typical procurement scope. Firms evaluating this code should confirm whether sodium lactate is actually being solicited under this UNSPSC designation in their target markets before committing pursuit resources.